{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:29:57Z","timestamp":1792189797100,"version":"4.4.0"},"reference-count":57,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The development and progression of ascites represent a crucial event in the natural history of patients with cirrhosis, predisposing them to other complications and carrying a heavy impact on prognosis. The current standard of care for the management of ascites relies on various combinations of diuretics and large-volume paracenteses. Periodic long-term albumin infusions on top of diuretics have been recently shown to greatly facilitate the management of ascites. The insertion of a transjugular intrahepatic portosystemic shunt (TIPS), an artificial connection between the portal and caval systems, is indicated to treat patients with refractory ascites. TIPS acts to decrease portal hypertension, thus targeting an upstream event in the pathophysiological cascade of cirrhosis decompensation. Available evidence shows a significant benefit on ascites control\/resolution, with less clear results on patient survival. Patient selection plays a crucial role in obtaining better clinical responses and avoiding TIPS-related adverse events, the most important of which are hepatic encephalopathy, cardiac overload and failure, and liver failure. At the same time, some recent technical evolutions of available stents appear promising but deserve further investigations. Future challenges and perspectives include (i) identifying the features for selecting the ideal candidate to TIPS; (ii) recognizing the better timing for TIPS placement; and (iii) understanding the most appropriate role of TIPS within the framework of all other available treatments for the management of patients with decompensated cirrhosis.<\/jats:p>","DOI":"10.3390\/jcm13051349","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T11:52:55Z","timestamp":1709034775000},"page":"1349","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis"],"prefix":"10.3390","volume":"13","author":[{"given":"Giulia","family":"Iannone","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy"},{"name":"Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-7027","authenticated-orcid":false,"given":"Enrico","family":"Pompili","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy"},{"name":"Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"De Venuto","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy"},{"name":"Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pratelli","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy"},{"name":"Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Tedesco","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7865-394X","authenticated-orcid":false,"given":"Maurizio","family":"Baldassarre","sequence":"additional","affiliation":[{"name":"Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caraceni","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy"},{"name":"Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3219-6963","authenticated-orcid":false,"given":"Giacomo","family":"Zaccherini","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy"},{"name":"Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural History and Prognostic Indicators of Survival in Cirrhosis: A Systematic Review of 118 Studies","volume":"44","author":"Pagliaro","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic Indicators of Survival in Patients with Compensated and Decompensated Cirrhosis","volume":"32","author":"Zipprich","year":"2012","journal-title":"Liver Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-Term Albumin Administration in Decompensated Cirrhosis (ANSWER): An Open-Label Randomised Trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.13968","article-title":"Long-Term Administration of Human Albumin Improves Survival in Patients with Cirrhosis and Refractory Ascites","volume":"39","author":"Fasolato","year":"2019","journal-title":"Liver Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral Arterial Vasodilation Hypothesis: A Proposal for the Initiation of Renal Sodium and Water Retention in Cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of Decompensation and Organ Failure in Cirrhosis: From Peripheral Arterial Vasodilation to Systemic Inflammation Hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of Decompensated Cirrhosis: Portal Hypertension, Circulatory Dysfunction, Inflammation, Metabolism and Mitochondrial Dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/00365518009091956","article-title":"Intraperitoneal Pressure: Ascitic Fluid and Splanchnic Vascular Pressures, and Their Role in Prevention and Formation of Ascites","volume":"40","author":"Henriksen","year":"1980","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cgh.2020.03.065","article-title":"Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis","volume":"19","author":"Tonon","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/liv.12583","article-title":"Adherence to a Moderate Sodium Restriction Diet in Outpatients with Cirrhosis and Ascites: A Real-life Cross-sectional Study","volume":"35","author":"Morando","year":"2015","journal-title":"Liver Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2008.176495","article-title":"Combined versus Sequential Diuretic Treatment of Ascites in Non-Azotaemic Patients with Cirrhosis: Results of an Open Randomised Clinical Trial","volume":"59","author":"Angeli","year":"2010","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and Albumin for Prevention of Complications in Patients with Cirrhosis Awaiting Liver Transplantation. A Randomized Placebo-Controlled Trial","volume":"69","author":"Castellote","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejim.2023.07.003","article-title":"Albumin Administration in Internal Medicine: A Journey between Effectiveness and Futility","volume":"117","author":"Pompili","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"ref_17","first-page":"9","article-title":"AISF-SIMTI Position Paper on the Appropriate Use of Albumin in Patients with Liver Cirrhosis: A 2020 Update","volume":"19","author":"Caraceni","year":"2021","journal-title":"Blood Transfus."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014Renewing Consensus in Portal Hypertension","volume":"76","author":"Bosch","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","article-title":"Clinical Events after Transjugular Intrahepatic Portosystemic Shunt: Correlation with Hemodynamic Findings","volume":"114","author":"Casado","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_20","first-page":"58","article-title":"Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Medically Refractory Ascites","volume":"20","author":"Parvinian","year":"2013","journal-title":"Diagn. Interv. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension","volume":"20","author":"Boike","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jhep.2014.01.015","article-title":"Covered vs. Uncovered Stents for Transjugular Intrahepatic Portosystemic Shunt: A Randomized Controlled Trial","volume":"60","author":"Perarnau","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","article-title":"Eight Millimetre Covered TIPS Does Not Compromise Shunt Function but Reduces Hepatic Encephalopathy in Preventing Variceal Rebleeding","volume":"67","author":"Wang","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1478-3231.2007.01522.x","article-title":"Patency of Stents Covered with Polytetrafluoroethylene in Patients Treated by Transjugular Intrahepatic Portosystemic Shunts: Long-Term Results of a Randomized Multicentre Study","volume":"27","author":"Bureau","year":"2007","journal-title":"Liver Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/liv.13615","article-title":"ePTFE-TIPS vs Repetitive LVP plus Albumin for the Treatment of Refractory Ascites in Patients with Cirrhosis","volume":"38","author":"Bucsics","year":"2018","journal-title":"Liver Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.cgh.2019.03.042","article-title":"Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased Survival","volume":"17","author":"Trebicka","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100264","DOI":"10.1016\/j.jhepr.2021.100264","article-title":"Controlled Underdilation Using Novel VIATORR\u00ae Controlled Expansion Stents Improves Survival after Transjugular Intrahepatic Portosystemic Shunt Implantation","volume":"3","author":"Praktiknjo","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100319","DOI":"10.1016\/j.jhepr.2021.100319","article-title":"The Clinical Advantage of Fixed 8-Mm Diameter VCX Stents over Underdilated VTS Stents Is Not Established in Refractory Ascites","volume":"3","author":"Mansour","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.dld.2015.08.014","article-title":"Circulatory Response to Volume Expansion and Transjugular Intrahepatic Portosystemic Shunt in Refractory Ascites: Relationship with Diastolic Dysfunction","volume":"47","author":"Falletta","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/gast.1997.v112.pm9041252","article-title":"The Mechanism of the Initial Natriuresis after Transjugular Intrahepatic Portosystemic Shunt","volume":"112","author":"Wong","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0002-9343(99)00029-7","article-title":"Long-Term Renal Sodium Handling in Patients with Cirrhosis Treated with Transjugular Intrahepatic Portosystemic Shunts for Refractory Ascites","volume":"106","author":"Wong","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jhep.2013.06.014","article-title":"TIPS: 25 years Later","volume":"59","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/hep.29612","article-title":"Increase in Liver Stiffness after Transjugular Intrahepatic Portosystemic Shunt Is Associated with Inflammation and Predicts Mortality","volume":"67","author":"Jansen","year":"2018","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular Intrahepatic Portosystemic Shunts: Comparison with Paracentesis in Patients with Cirrhosis and Refractory Ascites: A Randomized Trial. French Group of Clinicians and a Group of Biologists","volume":"25","author":"Lebrec","year":"1996","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites","volume":"342","author":"Ochs","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular Intrahepatic Portosystemic Shunting versus Paracentesis plus Albumin for Refractory Ascites in Cirrhosis","volume":"123","author":"Uriz","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American Study for the Treatment of Refractory Ascites","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized Controlled Study of TIPS versus Paracentesis plus Albumin in Cirrhosis with Severe Ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","article-title":"Transjugular Intrahepatic Portosystemic Shunt versus Paracentesis plus Albumin in Patients with Refractory Ascites Who Have Good Hepatic and Renal Function: A Prospective Randomized Trial","volume":"46","author":"Narahara","year":"2011","journal-title":"J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular Intrahepatic Portosystemic Shunts with Covered Stents Increase Transplant-Free Survival of Patients with Cirrhosis and Recurrent Ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis of Individual Patient Data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS Improves Liver Transplantation-Free Survival in Cirrhotic Patients with Refractory Ascites: An Updated Meta-Analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jhep.2005.06.005","article-title":"A Meta-Analysis of Transjugular Intrahepatic Portosystemic Shunt versus Paracentesis for Refractory Ascites","volume":"43","author":"Albillos","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2005.07.031","article-title":"Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis","volume":"129","author":"Luca","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1478-3231.2005.01095.x","article-title":"Transjugular Intrahepatic Portosystemic Shunt in Refractory Ascites: A Meta-Analysis","volume":"25","author":"Deltenre","year":"2005","journal-title":"Liver Int."},{"key":"ref_46","first-page":"CD004889","article-title":"TIPS versus Paracentesis for Cirrhotic Patients with Refractory Ascites","volume":"2006","author":"Saab","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.32704","article-title":"Mortality after Transjugular Intrahepatic Portosystemic Shunt in Older Adult Patients with Cirrhosis: A Validated Prediction Model","volume":"77","author":"Vizzutti","year":"2023","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00270-017-1848-1","article-title":"Symptomatic Heart Failure After Transjugular Intrahepatic Portosystemic Shunt Placement: Incidence, Outcomes, and Predictors","volume":"41","author":"Modha","year":"2018","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/hep.30934","article-title":"A Prospective Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular Intrahepatic Portosystemic Shunt: The Toulouse Algorithm","volume":"70","author":"Billey","year":"2019","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.dld.2018.01.123","article-title":"Transjugular Intrahepatic Portosystemic Shunt for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis","volume":"50","author":"Song","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.dld.2021.09.008","article-title":"Transjugular Intrahepatic Porto-Systemic Shunt in Cirrhotic Patients with Hepatorenal Syndrome-Chronic Kidney Disease: Impact on Renal Function","volume":"54","author":"Ponzo","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","article-title":"Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt with Polytetrafluoroethylene-Covered Stent Grafts","volume":"103","author":"Riggio","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","article-title":"Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Placement","volume":"15","author":"Nardelli","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.14309\/ajg.0000000000000959","article-title":"Sarcopenia Does Not Worsen Survival in Patients with Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites","volume":"115","author":"Benmassaoud","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3748\/wjg.v16.i3.348","article-title":"Body Composition Changes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis","volume":"16","author":"Montomoli","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.32596","article-title":"The Role of Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis and Ascites: Recent Evolution and Open Questions","volume":"77","author":"Deltenre","year":"2023","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jhep.2021.01.023","article-title":"Refining Prediction of Survival after TIPS with the Novel Freiburg Index of Post-TIPS Survival","volume":"74","author":"Bettinger","year":"2021","journal-title":"J. Hepatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/5\/1349\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:05:43Z","timestamp":1760105143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/5\/1349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["jcm13051349"],"URL":"https:\/\/doi.org\/10.3390\/jcm13051349","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]}}}